₹ 13838 / 11 shares
Issue Date
09 Feb - 13 Feb'24
Investment/lot
₹ 13838
Price Range
1195 - 1258
Lot Size
11
IPO Size
₹ 1600.84 Cr
Listing On
16 Feb'24
Issue Price
1258
Listed Price
₹ 1245
Retail Gain/Listing Gain
â–¼-2.33%
Entero Healthcare Solutions is amongst the top three healthcare product distributors in India, in terms of revenue, and reported an operating income of Rs. 25,220.65 million in FY22 (Source: CRISIL Report).
The company essentially provides reach and accessibility to pharmacies, hospitals and clinics through its integrated and technology-driven, pan-India distribution platform for healthcare products.
With that, let's take a look at the competitive strengths and risk factors for Entero Healthcare Solutions Limited:
One of India’s largest and fastest-growing healthcare products distribution platforms
Aside from being amongst the top three healthcare product distributors in India, the company also achieved the fastest scale-up of operations among healthcare product distributors in India (between FY19 to FY22) and reached Rs. 25,000 million of operating income within four years of operations (Source: CRISIL Report).
Track record of inorganic expansion and integration to grow geographic reach, revenues and scale
Since the inception of the company in FY18, it has acquired 32 entities in the healthcare products distribution industry. After the completion of an acquisition, the company deploys growth strategies such as product portfolio expansion, increased customer reach, improved service levels and technology-based solutions to increase market share.
The company operates in a large and highly fragmented Indian healthcare product distribution market
According to the CRISIL Report, the target addressable market for pharmaceutical distributors in India is valued at Rs. 2.7 trillion in FY23 and is expected to grow at 10% to 11% CAGR from FY23 to FY28. The company believes that it will be able to benefit from the market consolidation in India and continue expanding the business through future strategic acquisitions of local distributors.
Here are the key financials for Entero Healthcare Solutions Limited:
Particulars (in Rs. million)
Particulars (in Rs. million)
How to apply for IPO through ASBA
Kotak Securities
•4m 01s
Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO.
Here are the steps to apply for Entero Healthcare Solutions Ltd IPO:
Step 1: Log in to your Kotak Securities Demat account Log in to your Demat account to access IPO investments. Next, select the current IPO section.
Step 2: Specify IPO details Enter the number of lots and the price you wish to apply for.
Step 3: Enter UPI ID After entering your UPI ID, click submit. This will place your bid with the exchange.
Step 4: Mandate Notification Your UPI app will receive a mandate notification to block funds.
Step 5: Approve Request Your funds will be blocked once you approve the mandate request on your UPI.
Entero Healthcare Solutions Ltd IPO will list on 2024-02-16.
1600.84 is the issue size of Entero Healthcare Solutions Ltd IPO.
The minimum lot size is 11 shares and the investment required is ₹13838.
The price band of Entero Healthcare Solutions Ltd IPO is ₹1195 to ₹1258.
You can read more about Entero Healthcare Solutions Ltd and its IPO from the company’s red herring prospectus (RHP) here.
The Entero Healthcare Solutions Limited IPO has an issue size of Rs. 1,000 crores. The IPO opens for subscription on 9th February 2024 and closes on 13th February 2024.
Link Intime India Private Limited is the registrar for this IPO.
You may read more about Entero Healthcare Solutions Limited and its IPO from the company’s draft red herring prospectus (DRHP) here: